Home / Business / Business News / Third member of prestigious FDA panel resigns over approval of Biogen's Alzheimer's drug

Third member of prestigious FDA panel resigns over approval of Biogen's Alzheimer's drug

June 11, 2021 Business, Business News

A third member of a key FDA panel has resigned over the agency's controversial decision to approve Biogen's new Alzheimer's drug, Aduhelm, CNBC has learned.

from Business News https://ift.tt/3vbKoMx
via IFTTT https://ift.tt/eA8V8J

No comments

Subscribe to: Post Comments ( Atom )